Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

22 May, 2018, 15:14 BST Linköping University Hospital Second Swedish Site in Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer

Immunovia AB today announced that Linköping University Hospital is to participate in PanFAM-1, the largest ever prospective study looking at early...


22 May, 2018, 10:00 BST Renowned African Research Institutes Join Pediatric Praziquantel Consortium

Complementary experience offered by the Kenya Medical Research Institute (KEMRI) and the Université Félix Houphouët-Boigny (UFHB) in conducting...


22 May, 2018, 07:00 BST FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance

A highly innovative software, developed by Pie Medical Imaging - PMI - B.V. (Esaote Group) will be presented at EuroPCR 2018, the world-leading...


21 May, 2018, 10:45 BST Head-to-Head Trial Shows Refixia® Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia® (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those...


21 May, 2018, 10:20 BST NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today...


21 May, 2018, 09:00 BST NovoEight® Maintains Potency When Stored at 40ºC Offering People With Haemophilia A Increased Flexibility in Their Daily Lives

A new long term stability study has shown that haemophilia A treatment NovoEight® (turoctocog alfa) remains potent after three months exposure...


18 May, 2018, 13:04 BST LIXIANA® ▼ (edoxaban) Shows Reduced Rate of a Variety of Types of Intracranial Haemorrhage Compared to Warfarin in New Sub-analysis Presented at the European Stroke Organisation Conference 2018

- Sub-analysis presented from ENGAGE AF-TIMI 48, the longest single comparative global trial of a non-vitamin K oral anticoagulant...


18 May, 2018, 07:22 BST Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose™ FLU, in the Second Clinical Study

This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and...


18 May, 2018, 02:46 BST ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

ReCor Medical announced today that it will present the primary outcomes data from the SOLO study of its RADIANCE Global Clinical Trial Program of...


17 May, 2018, 13:30 BST Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)

Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients Receiving Conventional Therapy at...


16 May, 2018, 23:18 BST BerGenBio to Present Interim Clinical and Biomarker Data From Phase II Development Programme With Selective AXL Inhibitor Bemcentinib at ASCO

- Four peer reviewed BerGenBio abstracts on clinical data with bemcentinib accepted for presentation at ASCO - BerGenBio to host KOL...


16 May, 2018, 22:05 BST Daiichi Sankyo to Present New Data on Multiple Compounds Including Antibody Drug Conjugates DS-8201 and U3-1402 at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

- Updated results from the large ongoing phase 1 study of DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), in metastatic...


16 May, 2018, 13:00 BST AMPLEXOR's May Webinar Program Focuses on Digital Transformation in Life Sciences and Ensuring Compliance for the European Medical Device Regulations Part II

With a continued focus to present topics relevant to the Life Sciences industry, AMPLEXOR Life Sciences is pleased to announce its webinar program...


16 May, 2018, 11:58 BST iSTAR Medical's MINIject delivers exceptional 6-month results in first-in-human trial

iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional...


16 May, 2018, 11:14 BST Cantargia's Immuno-oncology Project CAN04 Shows Promise in Additional Cancer Forms

Cantargia AB today announces that the company has generated novel data showing high levels of interleukin-1 receptor accessory protein (IL1RAP) in...


16 May, 2018, 09:00 BST Sequana Medical Announces Inclusion of alfapump® in EASL Clinical Practice Guidelines and Presentation of Study Demonstrating Physical Component of QOL is Predictor of Mortality in Refractory Ascites

Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease &...


16 May, 2018, 09:00 BST Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study

Data from the study will be submitted to the FDA in support of Market Clearance for TIGERTRIEVER in the U.S. Rapid Medical, a company...


16 May, 2018, 07:00 BST BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common Medical Conditions

BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo...


15 May, 2018, 07:00 BST It Affects Over 1.5 Million People in the UK. [1],[2] In a Survey, 80% Report that it Impacts their Mood, Mental Health and Well-Being. But What is Atopic Dermatitis?

Not intended for Irish media - Atopic dermatitis is the most common type of eczema[3] - New public awareness campaign Scratch...


14 May, 2018, 09:00 BST Moorfields Eye Hospital Dubai in Collaboration with Moorfields Eye Hospital Abu Dhabi Develop Innovative Procedure to Diagnose Retinal Problems in Children

Medical Study Becomes the First Undertaken in the UAE to Be Published in Prestigious US Medical Journal A 'spoonful of sugar' proves...


14 May, 2018, 06:00 BST UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients

- BRIVIACT® (brivaracetam) CV oral formulations are approved as a monotherapy or adjunctive therapy in patients four years of age and older with...


10 May, 2018, 23:01 BST ESPGHAN Annual Meeting: New Study Finds Ginger Proven to Treat Vomiting in Children With Acute Gastroenteritis

Researchers presenting at the 51st ESPGHAN Annual Meeting have today revealed the results of a new study which proves the efficacy and...


10 May, 2018, 08:00 BST NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate

Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson's Stelara®, including...


09 May, 2018, 13:30 BST SeptiCyte™ LAB Differentiates Sepsis from SIRS in the ICU

Design and results of clinical trials that led to FDA clearance of SeptiCyte™ LAB published in the American Journal of Respiratory and Clinical...


08 May, 2018, 14:25 BST New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Alligator Bioscience and Aptevo Therapeutics

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed...